K. Gotting-Smith

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.

T. Tammela, L. Baert, P. Iversen, 1998, Urology.

Bicalutamide (Casodex®) in the treatment of prostate cancer: History of clinical development

G. Blackledge, G. Kolvenbag, G. Kolvenbag, 1998, The Prostate.